GSK plc

LSE:GSK Stock Report

Market Cap: UK£53.9b

GSK Management

Management criteria checks 2/4

GSK's CEO is Emma Walmsley, appointed in Apr 2017, has a tenure of 7.67 years. total yearly compensation is £12.72M, comprised of 10.3% salary and 89.7% bonuses, including company stock and options. directly owns 0.04% of the company’s shares, worth £21.32M. The average tenure of the management team and the board of directors is 6 years and 3.3 years respectively.

Key information

Emma Walmsley

Chief executive officer

UK£12.7m

Total compensation

CEO salary percentage10.3%
CEO tenure7.7yrs
CEO ownership0.04%
Management average tenure6yrs
Board average tenure3.3yrs

Recent management updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

May 02
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

Recent updates

Does GSK (LON:GSK) Have A Healthy Balance Sheet?

Dec 01
Does GSK (LON:GSK) Have A Healthy Balance Sheet?

GSK's (LON:GSK) Conservative Accounting Might Explain Soft Earnings

Nov 06
GSK's (LON:GSK) Conservative Accounting Might Explain Soft Earnings

GSK plc (LON:GSK) Not Flying Under The Radar

Nov 02
GSK plc (LON:GSK) Not Flying Under The Radar

GSK (LON:GSK) Is Paying Out A Dividend Of £0.15

Nov 02
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15

Does GSK (LON:GSK) Have A Healthy Balance Sheet?

Sep 01
Does GSK (LON:GSK) Have A Healthy Balance Sheet?

GSK (LON:GSK) Is Paying Out A Dividend Of £0.15

Aug 05
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15

GSK (LON:GSK) Will Pay A Dividend Of £0.15

May 05
GSK (LON:GSK) Will Pay A Dividend Of £0.15

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

May 02
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For GSK plc's (LON:GSK) CEO For Now

These 4 Measures Indicate That GSK (LON:GSK) Is Using Debt Reasonably Well

Apr 19
These 4 Measures Indicate That GSK (LON:GSK) Is Using Debt Reasonably Well

CEO Compensation Analysis

How has Emma Walmsley's remuneration changed compared to GSK's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

UK£3b

Jun 30 2024n/an/a

UK£4b

Mar 31 2024n/an/a

UK£4b

Dec 31 2023UK£13mUK£1m

UK£5b

Sep 30 2023n/an/a

UK£6b

Jun 30 2023n/an/a

UK£5b

Mar 31 2023n/an/a

UK£4b

Dec 31 2022UK£8mUK£1m

UK£4b

Sep 30 2022n/an/a

UK£3b

Jun 30 2022n/an/a

UK£4b

Mar 31 2022n/an/a

UK£4b

Dec 31 2021UK£8mUK£1m

UK£3b

Sep 30 2021n/an/a

UK£4b

Jun 30 2021n/an/a

UK£4b

Mar 31 2021n/an/a

UK£5b

Dec 31 2020UK£7mUK£1m

UK£5b

Sep 30 2020n/an/a

UK£6b

Jun 30 2020n/an/a

UK£7b

Mar 31 2020n/an/a

UK£5b

Dec 31 2019UK£8mUK£1m

UK£5b

Sep 30 2019n/an/a

UK£5b

Jun 30 2019n/an/a

UK£4b

Mar 31 2019n/an/a

UK£4b

Dec 31 2018UK£6mUK£1m

UK£4b

Sep 30 2018n/an/a

UK£2b

Jun 30 2018n/an/a

UK£2b

Mar 31 2018n/an/a

UK£1b

Dec 31 2017UK£5mUK£965k

UK£2b

Compensation vs Market: Emma's total compensation ($USD15.99M) is above average for companies of similar size in the UK market ($USD5.77M).

Compensation vs Earnings: Emma's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Emma Walmsley (55 yo)

7.7yrs

Tenure

UK£12,718,000

Compensation

Dame Emma N. Walmsley serves as an Independent Director of Microsoft Corp. since December 4, 2019. She serves as Chief Executive Officer of GlaxoSmithKline Plc since April 1, 2017. Dame Walmsley served as...

Leadership Team

NamePositionTenureCompensationOwnership
Emma Walmsley
CEO & Director7.7yrsUK£12.72m0.040%
£ 21.3m
Julie Brown
CFO & Executive Director1.7yrsUK£5.14m0.0024%
£ 1.3m
Shobie Ramakrishnan
Chief Digital & Technology Officer3.9yrsno datano data
Tony Wood
Chief Scientific Officer and Head of R&D2.3yrsno datano data
Nick Stone
SVP & Head of Investor Relationsno datano datano data
James Ford
Senior VP & Group General Counsel of Legal & Compliance6.3yrsno datano data
Sally Jackson
Senior Vice President of Global Communications & CEO Office5.8yrsno datano data
David Redfern
President of Corporate Developmentno datano datano data
Diana Conrad
Chief People Officer5.7yrsno datano data
Philip Thomson
President of Global Affairs7.7yrsno data0.0057%
£ 3.1m
Luke Miels
Chief Commercial Officer7.3yrsno datano data
Kevin Sin
Senior VP & Head of Worldwide Business Development for Pharmaceuticals Research Development6.5yrsno datano data

6.0yrs

Average Tenure

55yo

Average Age

Experienced Management: GSK's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Emma Walmsley
CEO & Director7.9yrsUK£12.72m0.040%
£ 21.3m
Julie Brown
CFO & Executive Director1.6yrsUK£5.14m0.0024%
£ 1.3m
Jonathan Symonds
Non-Executive Chairman5.3yrsUK£765.00k0.0020%
£ 1.1m
Vishal Sikka
Independent Non-Executive Director2.4yrsUK£147.00k0.00036%
£ 193.9k
Hal Barron
Non-Executive Director6.9yrsUK£356.92k0.032%
£ 17.3m
Harry Dietz
Independent Non-Executive Director2.9yrsUK£207.09k0.00016%
£ 86.2k
Anne Beal
Independent Non-Executive Director3.6yrsUK£174.93k0.00017%
£ 91.6k
Wendy Mira Becker
Independent Non-Executive Director1.2yrsUK£32.00k0.000040%
£ 21.5k
Charles Bancroft
Senior Independent Non-Executive Director4.6yrsUK£323.00k0.0014%
£ 764.8k
Tsun-Huei Lee
Independent Non-Executive Directorless than a yearno data0.000030%
£ 16.2k
Elizabeth Anderson
Independent Non-Executive Director2.3yrsUK£127.86k0.000090%
£ 48.5k
Jesse Goodman
Independent Non-Executive Director8.9yrsUK£173.36k0.00073%
£ 393.2k

3.3yrs

Average Tenure

62yo

Average Age

Experienced Board: GSK's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:25
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GSK plc is covered by 63 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamla SinghAlphaValue
John EadeArgus Research Company
Odile RundquistBaader Helvea Equity Research